FIELD: medicine
SUBSTANCE: what is presented is a trihybrid cell for protein expression, produced by hybridizing a first cell representing a stem cell or a cell originated from a virgin progenitor, a second cell originated from a common lymphoid progenitor, and a third cell originated from a common lymphoid progenitor, wherein the above first cell is other than a myeloma cell; a method for producing it and a method for producing proteins with using the same are also presented.
EFFECT: increasing protein stability produced by the above trihybrid cell and providing the more effective production of the therapeutic proteins ensure using the invention for protein expression applicable for diagnostic, preventive, therapeutic and/or scientific purposes.
64 cl, 62 dwg, 9 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF OBTAINING CELLS, DEMONSTRATING PHENOTYPIC PLASTICITY | 2010 |
|
RU2536941C2 |
| RECOMBINANT VECTOR OF CLONING | 1991 |
|
RU2116346C1 |
| SOLUBLE POLYPEPTIDE FRACTION OF PROTEIN LAG-3, METHOD OF PREPARING, THERAPEUTICAL COMPOSITION, ANTIBODY | 1995 |
|
RU2178306C2 |
| LABELED CHIMERIC EFFECTOR MOLECULES AND RECEPTORS THEREOF | 2014 |
|
RU2729463C2 |
| COMPOSITIONS AND METHODS FOR BOOSTING THE EFFECTIVENESS OF ADOPTIVE CELL IMMUNOTHERAPY | 2015 |
|
RU2716716C2 |
| METHOD AND COMPOSITIONS FOR TREATMENT OF PERSISTING INFECTIONS | 2006 |
|
RU2434641C2 |
| METHODS AND COMPOSITIONS FOR TREATMENT OF PERSISTENT INFECTIONS | 2016 |
|
RU2746383C2 |
| METHODS AND COMPOSITIONS FOR TREATING PERSISTENT INFECTIONS | 2006 |
|
RU2596491C2 |
| METHOD FOR OBTAINING UNDIFFERENTIATED CELL | 1996 |
|
RU2215539C2 |
| IMMUNE CELLS DEFECTIVE BY Suv39h1 | 2018 |
|
RU2784531C2 |
